PBA Health has received notice that Merck will reduce the WAC on Januvia, Janumet and Janumet XR beginning January 1, 2025.

There is uncertainty regarding IF there will be any reimbursement on inventory and HOW it will be handled. To be safe, PBA Health suggests you manage inventory on these products at year end by getting as close to zero as you can.

This will ensure there are no issues with the WAC reductions and existing inventory.

Watch for additional informational emails as new details become available.